Staged sentinel lymph node biopsy before mastectomy facilitates surgical planning for breast cancer patients - 18/08/11
, Benjamin F. Calvo, M.D. a, C. Scott Hultman, M.D. b, Hong Jin Kim, M.D. a, Michael O. Meyers, M.D. a, Lynn Damitz, M.D. b, Jill S. Frank, B.S. a, Karen B. Stitzenberg, M.D. a, Carolyn I. Sartor, M.D. c, David W. Ollila, M.D. aAbstract |
Background |
In patients with breast cancer who choose mastectomy with immediate reconstruction, the sentinel lymph node (SLN) status on permanent histology may complicate treatment if a metastasis is found. The purpose of this study was to determine how performing an SLN biopsy (SLNB) before the definitive operation would influence subsequent surgical procedures.
Methods |
Our SLN database was searched for patients who underwent staged SLNB with subsequent mastectomy between 2001 and 2004.
Results |
Twenty-five patients with 27 breast cancers underwent SLNB before mastectomy. Of them, 9 of 27 (33%) were node positive. All 9 patients underwent modified radical mastectomy. Three node-positive patients did not undergo immediate reconstruction. Of the remaining 6 node-positive patients, 5 underwent reconstruction with autologous tissue rather than a tissue expander. In contrast, 6 of 16 (37%) node-negative patients underwent reconstruction with a tissue expander.
Conclusions |
Staged SLNB assists in selecting the appropriate operation in patients who are considering immediate reconstruction.
Le texte complet de cet article est disponible en PDF.Keywords : Axillary lymph node dissection, Axillary staging, Postmastectomy radiation, Reconstruction, Transverse rectus abdominis musculocutaneous delay
Plan
Vol 190 - N° 4
P. 595-597 - octobre 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
